Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review

BACKGROUND: While data from several studies over the last decade has demonstrated that introduction of immunologic checkpoint blockage therapy with anti-CTLA-4/PD-1 drugs leads to improved survival in metastatic melanoma patients, relatively little is known about brain-specific therapeutic response...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Marin A., Sanghvi, Parag, Bykowski, Julie, Daniels, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943996/
https://www.ncbi.nlm.nih.gov/pubmed/29743050
http://dx.doi.org/10.1186/s12885-018-4470-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943996/
https://www.ncbi.nlm.nih.gov/pubmed/29743050
http://dx.doi.org/10.1186/s12885-018-4470-y

Ejemplares similares